Cost evaluation of pediatric acute infectious diseases of the nervous system

Maria Cecilia Graziani, D. Pellegrini, V. Di Ciommo, G. Di Liso, F. Ticca, T. Langiano

Research output: Contribution to journalArticle

Abstract

Objective. In 1995 the Italian Health Service (IHS) introduced a reimbursement method for hospitalization costs based on Diagnosis Related Groups (DRGs). In our hospital we determined costs of hospital care for children whose diseases fell within DRG 20 and 21 (infections of the central nervous system excluding viral meningitis, and viral meningitis, respectively), compared to the national tariffs reimbursed by the Italian Health Service. Methods. Clinical and treatment data were retrospectively retrieved from hospital records. Costs were provided by the accounting division. Results. In the period considered by our study, seventy children (age range 1 day-17 9/12 years) whose pathologies fell within DRG 20 and 21 were discharged; 5 of these (14.3%) had permanent sequelae and one died. Hospital stay varied between 17 and 146 days (median 22.5 days). The cost for patient care included in this study was € 718,520 (average cost for DRG 20: € 10,992.27; € 6,746.48 for DRG 21). The total amount reimbursed was € 381,874.43 (corresponding to 53% of the cost), with a difference between cost and reimbursements of € 336,645.72 Conclusions. While clinical data seem to be reassuring about the effectiveness of the therapeutic regimen, the costs sustained largely exceed those estimated by the reimbursement system.

Original languageEnglish
Pages (from-to)137-142
Number of pages6
JournalItalian Journal of Pediatrics
Volume29
Issue number2
Publication statusPublished - Apr 2003

Fingerprint

Acute Disease
Nervous System
Communicable Diseases
Diagnosis-Related Groups
Pediatrics
Costs and Cost Analysis
Viral Meningitis
Health Services
Central Nervous System Infections
Hospital Records
Hospital Costs
Child Care
Length of Stay
Patient Care
Hospitalization
Pathology
Therapeutics

Keywords

  • Cost
  • DRG
  • Infections
  • Nervous system
  • Paediatrics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Graziani, M. C., Pellegrini, D., Di Ciommo, V., Di Liso, G., Ticca, F., & Langiano, T. (2003). Cost evaluation of pediatric acute infectious diseases of the nervous system. Italian Journal of Pediatrics, 29(2), 137-142.

Cost evaluation of pediatric acute infectious diseases of the nervous system. / Graziani, Maria Cecilia; Pellegrini, D.; Di Ciommo, V.; Di Liso, G.; Ticca, F.; Langiano, T.

In: Italian Journal of Pediatrics, Vol. 29, No. 2, 04.2003, p. 137-142.

Research output: Contribution to journalArticle

Graziani, MC, Pellegrini, D, Di Ciommo, V, Di Liso, G, Ticca, F & Langiano, T 2003, 'Cost evaluation of pediatric acute infectious diseases of the nervous system', Italian Journal of Pediatrics, vol. 29, no. 2, pp. 137-142.
Graziani MC, Pellegrini D, Di Ciommo V, Di Liso G, Ticca F, Langiano T. Cost evaluation of pediatric acute infectious diseases of the nervous system. Italian Journal of Pediatrics. 2003 Apr;29(2):137-142.
Graziani, Maria Cecilia ; Pellegrini, D. ; Di Ciommo, V. ; Di Liso, G. ; Ticca, F. ; Langiano, T. / Cost evaluation of pediatric acute infectious diseases of the nervous system. In: Italian Journal of Pediatrics. 2003 ; Vol. 29, No. 2. pp. 137-142.
@article{fc8e9a209b384d579410fa7f9163fcaf,
title = "Cost evaluation of pediatric acute infectious diseases of the nervous system",
abstract = "Objective. In 1995 the Italian Health Service (IHS) introduced a reimbursement method for hospitalization costs based on Diagnosis Related Groups (DRGs). In our hospital we determined costs of hospital care for children whose diseases fell within DRG 20 and 21 (infections of the central nervous system excluding viral meningitis, and viral meningitis, respectively), compared to the national tariffs reimbursed by the Italian Health Service. Methods. Clinical and treatment data were retrospectively retrieved from hospital records. Costs were provided by the accounting division. Results. In the period considered by our study, seventy children (age range 1 day-17 9/12 years) whose pathologies fell within DRG 20 and 21 were discharged; 5 of these (14.3{\%}) had permanent sequelae and one died. Hospital stay varied between 17 and 146 days (median 22.5 days). The cost for patient care included in this study was € 718,520 (average cost for DRG 20: € 10,992.27; € 6,746.48 for DRG 21). The total amount reimbursed was € 381,874.43 (corresponding to 53{\%} of the cost), with a difference between cost and reimbursements of € 336,645.72 Conclusions. While clinical data seem to be reassuring about the effectiveness of the therapeutic regimen, the costs sustained largely exceed those estimated by the reimbursement system.",
keywords = "Cost, DRG, Infections, Nervous system, Paediatrics",
author = "Graziani, {Maria Cecilia} and D. Pellegrini and {Di Ciommo}, V. and {Di Liso}, G. and F. Ticca and T. Langiano",
year = "2003",
month = "4",
language = "English",
volume = "29",
pages = "137--142",
journal = "Italian Journal of Pediatrics",
issn = "1720-8424",
publisher = "BioMed Central Ltd.",
number = "2",

}

TY - JOUR

T1 - Cost evaluation of pediatric acute infectious diseases of the nervous system

AU - Graziani, Maria Cecilia

AU - Pellegrini, D.

AU - Di Ciommo, V.

AU - Di Liso, G.

AU - Ticca, F.

AU - Langiano, T.

PY - 2003/4

Y1 - 2003/4

N2 - Objective. In 1995 the Italian Health Service (IHS) introduced a reimbursement method for hospitalization costs based on Diagnosis Related Groups (DRGs). In our hospital we determined costs of hospital care for children whose diseases fell within DRG 20 and 21 (infections of the central nervous system excluding viral meningitis, and viral meningitis, respectively), compared to the national tariffs reimbursed by the Italian Health Service. Methods. Clinical and treatment data were retrospectively retrieved from hospital records. Costs were provided by the accounting division. Results. In the period considered by our study, seventy children (age range 1 day-17 9/12 years) whose pathologies fell within DRG 20 and 21 were discharged; 5 of these (14.3%) had permanent sequelae and one died. Hospital stay varied between 17 and 146 days (median 22.5 days). The cost for patient care included in this study was € 718,520 (average cost for DRG 20: € 10,992.27; € 6,746.48 for DRG 21). The total amount reimbursed was € 381,874.43 (corresponding to 53% of the cost), with a difference between cost and reimbursements of € 336,645.72 Conclusions. While clinical data seem to be reassuring about the effectiveness of the therapeutic regimen, the costs sustained largely exceed those estimated by the reimbursement system.

AB - Objective. In 1995 the Italian Health Service (IHS) introduced a reimbursement method for hospitalization costs based on Diagnosis Related Groups (DRGs). In our hospital we determined costs of hospital care for children whose diseases fell within DRG 20 and 21 (infections of the central nervous system excluding viral meningitis, and viral meningitis, respectively), compared to the national tariffs reimbursed by the Italian Health Service. Methods. Clinical and treatment data were retrospectively retrieved from hospital records. Costs were provided by the accounting division. Results. In the period considered by our study, seventy children (age range 1 day-17 9/12 years) whose pathologies fell within DRG 20 and 21 were discharged; 5 of these (14.3%) had permanent sequelae and one died. Hospital stay varied between 17 and 146 days (median 22.5 days). The cost for patient care included in this study was € 718,520 (average cost for DRG 20: € 10,992.27; € 6,746.48 for DRG 21). The total amount reimbursed was € 381,874.43 (corresponding to 53% of the cost), with a difference between cost and reimbursements of € 336,645.72 Conclusions. While clinical data seem to be reassuring about the effectiveness of the therapeutic regimen, the costs sustained largely exceed those estimated by the reimbursement system.

KW - Cost

KW - DRG

KW - Infections

KW - Nervous system

KW - Paediatrics

UR - http://www.scopus.com/inward/record.url?scp=0038801721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038801721&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 137

EP - 142

JO - Italian Journal of Pediatrics

JF - Italian Journal of Pediatrics

SN - 1720-8424

IS - 2

ER -